JOHNSON & JOHNSON Non-operating Income/Expense 2007-2026 | JNJ
Beta
What is JOHNSON & JOHNSON's current non-operating income/expense?
JOHNSON & JOHNSON (JNJ) annual non-operating income/expense for 2025 was $7.21B, a 253.58% increase from 2024. JOHNSON & JOHNSON non-operating income/expense for the quarter ending March 29, 2026 was $-294.0M.
What was JOHNSON & JOHNSON's non-operating income/expense in 2024?
JOHNSON & JOHNSON annual non-operating income/expense for 2024 was $-4.69B, a 29.24% increase from 2023.
What was JOHNSON & JOHNSON's non-operating income/expense in 2023?
JOHNSON & JOHNSON annual non-operating income/expense for 2023 was $-6.63B, a 1161.22% decline from 2022.
Non-operating Income/Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2019
$-2.52B
→
FY2025
$7.21B
07081011121314161718192122232425
5 years selected
Non-operating Income/Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $7.21B | +253.6% | 10-K |
| FY2024 | $-4.69B | +29.2% | 10-K |
| FY2023 | $-6.63B | -1161.2% | 10-K |
| FY2022 | $-526.0M | +81.9% | 10-K |
| FY2021 | $-2.90B | -14.8% | 10-K |
| FY2019 | $-2.52B | -79.7% | 10-K |
| FY2018 | $-1.41B | -3445.2% | 10-K |
| FY2017 | $42.0M | -98.0% | 10-K |
| FY2016 | $2.06B | +2848.6% | 10-K |
| FY2014 | $70.0M | +102.8% | 10-K |
| FY2013 | $-2.50B | -53.6% | 10-K |
| FY2012 | $-1.63B | -311.7% | 10-K |
| FY2011 | $768.0M | +46.0% | 10-K |
| FY2010 | $526.0M | -48.2% | 10-K |
| FY2008 | $1.01B | +290.1% | 10-K |
| FY2007 | $-534.0M | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →